| Protocol No. | NCI-CIRB-10522-PMC |
| Title | NCI-CIRB-10522-PMC: A Phase 1 Clinical Trial of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Metastatic or Unresectable Pancreatic Ductal Carcinoma |
| NCT Number | NCT05685602 (Click to open a new window to clinicaltrials.gov) |
| Principal Investigator | Patel, Reema |
| Cancer Types | Pancreas |
| Phase | Phase I |
| Age Group | Adult |
| Drugs Involved | CA-4948; Gemzar (gemcitabine); gemcitabine; nab-paclitaxel (Abraxane) |
| Status | Open |
| Participating Institutions | Markey Cancer Center; University of Kentucky Medical Center |